Detalles de la búsqueda
1.
Venetoclax-based combinations for the treatment of newly diagnosed acute myeloid leukemia.
Future Oncol
; 17(23): 2989-3005, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34024158
2.
Guardant360 Circulating Tumor DNA Assay Is Concordant with FoundationOne Next-Generation Sequencing in Detecting Actionable Driver Mutations in Anti-EGFR Naive Metastatic Colorectal Cancer.
Oncologist
; 25(3): 235-243, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32162812
3.
Rebound thrombocytosis is associated with response in AML patients treated with venetoclax and hypomethylating agents.
Am J Hematol
; 96(5): E140-E143, 2021 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33524204
4.
Impact of Thiotepa-Based Autologous Hematopoietic Cell Transplantation in Primary Central Nervous System Lymphoma in First Complete Remission: A University of California Hematologic Malignancies Consortium Retrospective Analysis.
Clin Lymphoma Myeloma Leuk
; 23(10): 749-756, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37336714
5.
Role of Salvage Radiation Treatment of Relapses in Relapsed/Refractory Diffuse Large B Cell Lymphoma Post-Autologous Stem Cell Transplant.
Int J Radiat Oncol Biol Phys
; 113(3): 594-601, 2022 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35176414
6.
R-CHOP Vs DA-EPOCH-R for Double-Expressor Lymphoma: A University of California Hematologic Malignancies Consortium Retrospective Analysis.
Clin Lymphoma Myeloma Leuk
; 22(10): e947-e957, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35858904
7.
Clinical experience with frontline Hyper-CVAD-based regimens, including Hyper-CVAD plus ponatinib, in patients with acute lymphoblastic leukemia treated at a comprehensive cancer center.
Leuk Res
; 119: 106885, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35738024
8.
Emerging Therapies in Relapsed and Refractory Hodgkin Lymphoma: What Comes Next After Brentuximab Vedotin and PD-1 Inhibition?
Curr Hematol Malig Rep
; 16(1): 1-7, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33409966
9.
An evaluation of venetoclax in combination with azacitidine, decitabine, or low-dose cytarabine as therapy for acute myeloid leukemia.
Expert Rev Hematol
; 14(5): 407-417, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34076549
10.
Combined Cerebellar and Spinal Cord Deficits Caused by an Underlying Gynecologic Malignancy.
Case Rep Oncol Med
; 2020: 9021843, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31970005
11.
Characteristics and Trends of Adult Acute Lymphoblastic Leukemia in a Large, Public Safety-Net Hospital.
Clin Lymphoma Myeloma Leuk
; 20(6): e320-e327, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32199763
12.
Inherited Moderate Factor X Deficiency Presenting as Cardiac Tamponade.
Case Rep Hematol
; 2019: 9657516, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31662920
13.
Yttrium-90 ibritumomab tiuxetan plus ATG/TLI for allogeneic hematopoietic cell transplantation in non-Hodgkin lymphoma.
Bone Marrow Transplant
; 58(10): 1143-1145, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37391654
14.
Allogeneic hematopoietic cell transplantation using non-myeloablative ATG/TLI conditioning for lymphomas.
Leuk Lymphoma
; 63(1): 231-234, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34486920
15.
Retreatment with venetoclax and hypomethylating agents among AML patients who have relapsed after initial response and subsequent interruption of therapy.
Leuk Lymphoma
; 61(14): 3532-3533, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32811233
Resultados
1 -
15
de 15
1
Próxima >
>>